Studies have shown that active fund managers routinely underperform the S&P500 index*​

Bright Minds Biosciences Inc. (DRUG) Stock Forecast 2027–2031

DRUG Price Today

$54.98

DRUG Stock Ratings

WSX Rating: HOLD
Consensus Rating: STRONG BUY

DRUG Price Targets

MonthCloseTotal,%
2026
Nov$55.641.20%
Dec$56.041.93%
2027
Jan$56.282.36%
Feb$55.881.64%
Mar$56.082.00%
Apr$56.502.76%
May$56.292.38%
Jun$56.011.87%
Jul$56.342.47%
Aug$55.971.80%
Sep$55.220.44%
Oct$55.340.65%
Nov$56.001.86%
Dec$56.412.60%
2028
Jan$56.643.02%
Feb$56.242.29%
Mar$56.442.66%
Apr$56.863.42%
May$56.663.06%
Jun$56.372.53%
Jul$56.713.15%
Aug$56.332.46%
Sep$55.571.07%
Oct$55.691.29%
Nov$56.362.51%
Dec$56.773.26%
2029
Jan$57.003.67%
Feb$56.602.95%
Mar$56.803.31%
Apr$57.234.09%
May$57.023.71%
Jun$56.733.18%
Jul$57.073.80%
Aug$56.693.11%
Sep$55.931.73%
Oct$56.051.95%
Nov$56.723.16%
Dec$57.133.91%
2030
Jan$57.374.35%
Feb$56.963.60%
Mar$57.173.98%
Apr$57.594.75%
May$57.384.37%
Jun$57.093.84%
Jul$57.434.46%
Aug$57.053.77%
Sep$56.282.36%
Oct$56.402.58%
Nov$57.083.82%
Dec$57.494.57%
2031
Jan$57.735.00%
Feb$57.324.26%
Mar$57.534.64%
Apr$57.965.42%
May$57.755.04%
Jun$57.454.49%
Jul$57.805.13%
Aug$57.414.42%
Sep$56.643.02%
Oct$56.763.24%

The DRUG stock price forecast for 2026 is $56.04, which is a change of +1.93% over today.

The DRUG stock price forecast for 2027 is $56.50, which is a change of +2.76% over today.

The DRUG stock price forecast for 2028 is $56.86, which is a change of +3.42% over today.

The DRUG stock price forecast for 2029 is $57.23, which is a change of +4.09% over today.

The DRUG stock price forecast for 2030 is $57.59, which is a change of +4.75% over today.

The DRUG stock price forecast for 2031 is $57.96, which is a change of +5.42% over today.

Is DRUG Stock a Buy?

Bright Minds Biosciences Inc. (DRUG) earns a HOLD rating because its forecast indicates 0.65% price appreciation over the next 12 months. Its revenue growth is low relative to the market, while the forecast remains sensitive to future business and market performance.

Is DRUG Stock a Good Long-Term Investment?

DRUG stock is not a good long-term investment because its HOLD Wall Street X rating and expected revenue growth of 0.00% support a watchlist approach rather than a clear buying case, with our models projecting a 2031 price of $57.96 (+5.42% compared to today’s price).

Can DRUG stock reach $200?

Our model is not projecting that DRUG will hit $200 within the five-year forecast, with its 2031 forecast reaching $57.96 (+5.42% over today’s price).

DRUG Frequently Asked Questions

What is DRUG stock rated?

Wall Street X rates DRUG a HOLD, and the average consensus rating is a STRONG BUY.

Wall Street X has a one year price target of $55.34 for DRUG.

To buy shares of DRUG, open an account with an online brokerage, deposit money from your bank, search for “DRUG”, choose the number of shares or dollar amount, and place a trade.

Popular Articles

DRUG forecast data was last updated on by wallstreetx.com staff.

How Wall Street X Rates Stocks

Bookmark this page to check for updates:
on iPhone/iPad tap the Share icon Share. Select Add to Favorites, then Add.
on Android tap the 3-dots icon 3-dot at the top right. Tap Add to Favorites, then Add.
on PC press buttons Ctrl + D or click the star star next to the browser bar at the top.

Trending Stocks This Week

Loading…

JOIN OUR NEWSLETTER WAITLIST

Daily trending stocks, portfolio updates, upgrades/downgrades, and latest articles.

DRUG Price Target Calculator

Interactive calculator

Adjust growth and future valuation assumptions to estimate a stock price target.

Estimated target price$0.00
Potential return+0.0%
Current price supplied by your stock data
1.06%
Current multiple supplied by your stock data
Projected price by yearUSD
Stock forecastS&P 500 (10.4% annually)